skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: hi, alz is a ticker symbol being used by solo growth.solo liquor stores are converting some stores to cannabis stores.Is this investible as a consumer discretion stock.What kind of profit will just a retailer make in this space....they have plans for 100 stores in Ontario and 50 in Alberta.
Move on or interesting?
Read Answer Asked by Brad on September 19, 2018
Q: Good Morning 5i Do you have any idea as to why Tilray is rising so fast? I'm holding long on Canopy for this sector and not intending to sell this year. And not intending to buy Tilray. Is Tilray's rise likely to pull upward sp of WEED up faster? Also talk of large short positions in the sector. Any background thoughts on what is happening as we approach Oct. 17th. ?
Read Answer Asked by Randy on September 19, 2018
Q: Hello Peter,
Namaste seems to follow the Amazon model and if they get the medical sales license, they could do quite well given their international exposure. Signing a deal with Tilray was a good endorsement;however, it is unclear at this point, what really transpired that would cause Tilray to cancel the agreement. I have not seen any official release from either company other than the Quebec newspaper article. The stock is down quite a bit. What should one do in this case? If the agreement is truly cancelled, should one sell or hang on as the overall model looks good. My concern is could the perception of the company be ruined and hence investor perception? Thanks
Read Answer Asked by umedali on September 18, 2018
Q: This company seems to have changed its focus drastically within the cannabis space since your last assessment in Jan. Could you update the outlook for the company, including the spinout of Poda. Scotia research forecasts .04 earnings in 2019 and .13 in 2020; achievable?
Its trading symbol has changed, now GENE, perhaps to reflect the involvement of its Chief Evangelist Officer, Gene Simmons, whom I know Peter will meet on Friday. Perhaps Peter could find out the duties of a C.E.O.?
Read Answer Asked by Jeff on September 17, 2018
Q: Currently own a 4% position of Dollarama and after the disappointment today was thinking of switching over to Covalon as a replacement. Looking out 3+ years would you look at this as a better long term strategy? Starting to worry the Dollar store space could get crowded in the coming years.
Read Answer Asked by Patrick on September 14, 2018
Q: ray.a is your top pick on BNN but is not in any of your portfolio, why ? At current price between mfc and slf which is a better buy ? After the recent news of the awards of contracts is maxr an attractive buy ?
Read Answer Asked by c c on September 13, 2018
Q: Peter; Just a comment - it seems to me all the cannabis stocks are basiallly mimicking CPG in its hey days of using its share price to acquire other companies and assets. And now look at it. ! Rod
Read Answer Asked by Rodney on September 11, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!